141 related articles for article (PubMed ID: 25648517)
21. High-resolution structure of native toxin A from Clostridioides difficile.
Aminzadeh A; Larsen CE; Boesen T; Jørgensen R
EMBO Rep; 2022 Jan; 23(1):e53597. PubMed ID: 34817920
[TBL] [Abstract][Full Text] [Related]
22. Isofagomine inhibits multiple TcdB variants and protects mice from
Paparella AS; Brew I; Hong HA; Ferriera W; Cutting S; Lamiable-Oulaidi F; Popadynec M; Tyler PC; Schramm VL
bioRxiv; 2023 Sep; ():. PubMed ID: 37781587
[No Abstract] [Full Text] [Related]
23. Novel Dietary Proteins Selectively Affect Intestinal Health In Vitro after
Jochems PGM; Garssen J; Rietveld PCS; Govers C; Tomassen MMM; Wichers HJ; van Bergenhenegouwen J; Masereeuw R
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32932980
[TBL] [Abstract][Full Text] [Related]
24. Prosurvival Pathway Protects From Clostridioides difficile Toxin-Mediated Cell Death.
Tornel W; Sharma I; Osmani H; Moonah S
J Infect Dis; 2024 May; 229(5):1519-1522. PubMed ID: 37972231
[TBL] [Abstract][Full Text] [Related]
25. Protective Effects of Alginate and Chitosan Oligosaccharides against
Mavrogeni ME; Asadpoor M; Judernatz JH; van Ark I; Wösten MMSM; Strijbis K; Pieters RJ; Folkerts G; Braber S
Toxins (Basel); 2023 Sep; 15(10):. PubMed ID: 37888617
[No Abstract] [Full Text] [Related]
26. Conformational analysis of Clostridium difficile toxin B and its implications for substrate recognition.
Swett R; Cisneros GA; Feig AL
PLoS One; 2012; 7(7):e41518. PubMed ID: 22844485
[TBL] [Abstract][Full Text] [Related]
27. Nectin-3 and shed forms of CSPG4 can serve as epithelial cell receptors for
Childress KO; Cencer CS; Tyska MJ; Lacy DB
mBio; 2023 Oct; 14(5):e0185723. PubMed ID: 37747247
[TBL] [Abstract][Full Text] [Related]
28. CSPG4-dependent cytotoxicity for
Doyle DA; DeAngelis PL; Ballard JD
mSphere; 2024 Apr; 9(4):e0009424. PubMed ID: 38470254
[TBL] [Abstract][Full Text] [Related]
29. Identification of a hemorrhagic determinant in
Zheng Y; Yang Q; Luo J; Zhang Y; Li X; He L; Ma C; Tao L
Microbiol Spectr; 2024 Jun; 12(6):e0035424. PubMed ID: 38709085
[No Abstract] [Full Text] [Related]
30. Protease-stable DARPins as promising oral therapeutics.
Simeon RA; Zeng Y; Chonira V; Aguirre AM; Lasagna M; Baloh M; Sorg JA; Tommos C; Chen Z
Protein Eng Des Sel; 2021 Feb; 34():. PubMed ID: 34882774
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of EGFR/ErbB does not protect against
Siddiqi U; Lunnemann HM; Childress KO; Shupe JA; Rutherford SA; Farrow MA; Washington MK; Coffey RJ; Lacy DB; Markham NO
bioRxiv; 2024 May; ():. PubMed ID: 38798529
[No Abstract] [Full Text] [Related]
32. Engineered Secretory Immunoglobulin A provides insights on antibody-based effector mechanisms targeting
Bharathkar SK; Miller MJ; Stadtmueller BM
bioRxiv; 2023 Nov; ():. PubMed ID: 37986930
[TBL] [Abstract][Full Text] [Related]
33. Effect of
Yang J; Yang H
Front Microbiol; 2018; 9():2953. PubMed ID: 30564210
[TBL] [Abstract][Full Text] [Related]
34. Toxin synthesis by Clostridium difficile is regulated through quorum signaling.
Darkoh C; DuPont HL; Norris SJ; Kaplan HB
mBio; 2015 Feb; 6(2):e02569. PubMed ID: 25714717
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B.
Eckert C; Emirian A; Le Monnier A; Cathala L; De Montclos H; Goret J; Berger P; Petit A; De Chevigny A; Jean-Pierre H; Nebbad B; Camiade S; Meckenstock R; Lalande V; Marchandin H; Barbut F
New Microbes New Infect; 2015 Jan; 3():12-7. PubMed ID: 25755885
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile.
Fawley WN; Knetsch CW; MacCannell DR; Harmanus C; Du T; Mulvey MR; Paulick A; Anderson L; Kuijper EJ; Wilcox MH
PLoS One; 2015; 10(2):e0118150. PubMed ID: 25679978
[TBL] [Abstract][Full Text] [Related]
37. The prospect for vaccines to prevent Clostridium difficile infection.
Ghose C; Kelly CP
Infect Dis Clin North Am; 2015 Mar; 29(1):145-62. PubMed ID: 25677708
[TBL] [Abstract][Full Text] [Related]
38. Variation in germination of Clostridium difficile clinical isolates correlates to disease severity.
Carlson PE; Kaiser AM; McColm SA; Bauer JM; Young VB; Aronoff DM; Hanna PC
Anaerobe; 2015 Jun; 33():64-70. PubMed ID: 25681667
[TBL] [Abstract][Full Text] [Related]
39. Preface: Clostridium difficile Infection.
Wilcox MH
Infect Dis Clin North Am; 2015 Mar; 29(1):xiii-xiv. PubMed ID: 25677709
[No Abstract] [Full Text] [Related]
40. The morbidity, mortality, and costs associated with Clostridium difficile infection.
Kwon JH; Olsen MA; Dubberke ER
Infect Dis Clin North Am; 2015 Mar; 29(1):123-34. PubMed ID: 25677706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
